|
 |
|
Home > In Vitro Diagnostics |
|
|
|
|
In Vitro Diagnostics Market Research Reports |
Japan Blood Banking Market: Test Volume and Reagent Sales Forecasts by Market Segment, Key Supplier Shares
This report provides an overview of the Japanese blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening tests, as well as test volume and sales forecasts by market segment.
|
 |
|
$1450.00 |
|
|
|
|
Spain Blood Banking Market: Test Volume and Reagent Sales Forecasts by Market Segment, Key Supplier Shares
This report provides an overview of the Spanish blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well as test volume and sales forecasts by market segment.
|
 |
|
$1450.00 |
|
|
|
|
The UK Blood Banking Market: Test Volume and Reagent Sales Forecasts by Market Segment, Key Supplier Shares
This report provides an overview of the UK blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening tests, as well as test volume and sales forecasts by market segment.
|
 |
|
$1450.00 |
|
|
|
|
Herpes Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--France, Germany, Italy, Japan, Spain, UK, USA--Hospitals, Commercial and Public Health Labs, POC Locations
This report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Herpes Simplex I/II and Herpes Type VI tests performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
France HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents French test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot, and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
Germany HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents German test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
Italy HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents Italian test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
Japan HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents Japanese test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
Spain HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents Spanish test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
UK HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents the UK test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
US HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
 |
|
$1450.00 |
|
|
|
|
Home/Self-Testing Diagnostic Market: Diabetes, Pregnancy, Ovulation, Occult Blood Business Challenges and Marketing Strategies for Suppliers
This new 175-page report from Venture Planning Group provides analysis of the major home/self-testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.
|
 |
|
$1450.00 |
|
|
|
|
US Home/Self-Testing Diagnostic Market: Diabetes, Pregnancy, Ovulation, Occult Blood--Business Challenges and Marketing Strategies for Suppliers
This new 175-page report from Venture Planning Group provides analysis of the major home/self-testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.
|
 |
|
$1450.00 |
|
|
|
|
Cancer Molecular Diagnostic Testing
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing.Contains 45 pages and 1 table
|
 |
|
$1450.00 |
|
|
|
|
France Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
|
 |
|
$1450.00 |
|
|
|
|
Germany Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
|
 |
|
$1450.00 |
|
|
|
|
Italy Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
This new study from Venture Planning Group contains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
|
 |
|
$1450.00 |
|
|
|
|
Japan Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
This new study from Venture Planning Group contains 620 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
|
 |
|
$1450.00 |
|
|
|
|
|